Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06470763
Title A Study Evaluating ANV600 Single Agent or in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (EXPAND-1)
Acronym EXPAND-1
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Anaveon AG
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | FRA | ESP | DEU | CHE

Facility Status City State Zip Country Details
Fox Chase Cancer Center RECRUITING Philadelphia Pennsylvania 19111 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
Institut Bergonie RECRUITING Bordeaux France Details
CEPCM - AP-HM Hopital de la Timone RECRUITING Marseille France Details
Oncopole Claudius Regaud, Toulouse RECRUITING Toulouse France Details
Institut Gustave Roussy RECRUITING Villejuif France Details
Charite Universitaetsmedizin Berlin RECRUITING Berlin Germany Details
Krankenhaus Nordwest - Institut für Klinisch-Onkologische Forschung (IKF) RECRUITING Frankfurt Germany Details
Universitaetsmedizin der Johannes Gutenberg - Universitaet Mainz RECRUITING Mainz Germany Details
Nederlands Kanker Instituut - Antoni van Leeuwenhoek (NKI-AVL) RECRUITING Amsterdam Netherlands Details
START Madrid CIOCC RECRUITING Madrid Spain Details
Clinica Universidad de Navarra - Pamplona RECRUITING Pamplona Spain Details
INCLIVA Foundation RECRUITING Valencia Spain Details
Ente Ospedaliero Cantonale - Istituto Oncologico della Svizzera Italiana RECRUITING Bellinzona Switzerland Details
Cantonal Hospital St Gallen RECRUITING St Gallen Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field